A carefully evaluates whether lower-dose metabolic support or more adjusted protocols are appropriate based on each patients goals, health history, tolerance, and response
Glucagon-like peptide-2 but not imipramine exhibits antidepressant-like effects in ACTH-treated mice
[21] For patients undergoing surgery , the approach should be individualised based on several factors: Aspiration risk assessment : Patients with symptoms of gastroparesis, those on high doses, or those who have recently initiated therapy may have increased risk Type of surgery : Particularly procedures involving the gastrointestinal tract Indication for GLP-1 therapy : Whether for diabetes management or weight loss If GLP-1 medications are temporarily withheld based on individual risk assessment or local policy, patients with diabetes should have a clear plan for glycaemic management, including capillary glucose monitoring and potential bridging therapy, developed in consultation with the diabetes team
Magnesium supplementation: Magnesium citrate or magnesium oxide at 200-400mg daily can improve colonic motility without harsh stimulant effects
Natural plant-based ingredients (e.g., aloe/hops) ensure gentle, well-tolerated daily supplementation
Your healthcare provider can evaluate whether compounded semaglutide is best for your weight loss treatment plan
